-
A study of thermal spa baths for chronic low back pain revealed some benefits over warm tap water baths. However, multiple hypothesis testing takes away from the confidence clinicians can have regarding the true effect. Nonetheless, all patients improved during and after the treatment period of daily baths.
-
In an initial investigation of the potential for information from CAM research to influence clinical practice, a 2007 national survey asked acupuncturists, naturopaths, internists, and rheumatologists about their awareness of CAM clinical trials, ability to interpret research results, and use of research evidence in decision making.
-
This small pilot study represents the first controlled assessment of intravenous micronutrient therapy for fibromyalgia. No statistically significant benefit over placebo was identified, though clinical benefit was apparent, and feasibility was established. Regardless of one's bias regarding this type of care, further study is needed.
-
Upon evaluating data from the STAR*D project, researchers concluded that phase III clinical trials often do not recruit representative populations of depressed outpatients, making the recommendations drawn from the studies' conclusions of limited applicability to general clinical practice.
-
A brief intervention of an extract of ginger administered four times daily was effective in ameliorating nausea and vomiting of pregnancy in this small single-blind trial.
-
Heart failure (HF), the end result of many cardiovascular disorders and a common disabling clinical syndrome, affects almost 6 million people in the United States.
-
How is your facility coping with the current economic downturn? Look to the July issue of Contraceptive Technology Update for special focus articles that will report on such up-to-the-moment items as these:
-
The Food and Drug Administration (FDA) is complying with a federal judge's instruction and is directing the manufacturers of the dedicated emergency contraceptive pill Plan B to make the drug available to 17-year-olds without prescription.
-
Women who have been searching for the Today contraceptive sponge on pharmacy shelves can stop hunting: Mayer Laboratories now serves as the U.S. distributor for the over-the-counter contraceptive.
-
If your practice includes care of pregnant women, be sure to review just-issued interim guidance from the Centers for Disease Control and Prevention (CDC) in regard to swine influenza A (H1N1) virus infection.
